Although no prior studies have specifically examined CD40 and CD40L levels in laryngeal cancer, research on other cancer types consistently reports an increase in CD40L levels alongside elevated CD40 levels in malignancies. This evidence concerns the gene CD40 and laryngeal carcinoma.